An 18-year interval between a dengue virus type 1 outbreak in 1977-1979 and
a dengue virus type 2 outbreak in 1997 in Santiago de Cuba, Cuba, provided
a unique opportunity to evaluate risk factors for dengue disease. All pati
ents with symptomatic dengue, including 205 cases of dengue hemorrhagic fev
er and 12 deaths, were adults born before the dengue virus type 1 epidemic,
and nearly all (98%) experienced secondary dengue virus infections. In con
trast, almost all of those who seroconverted without illness (97%) experien
ced primary dengue virus infection. This provides epidemiologic support for
the immune enhancement theory of dengue pathogenesis. The Cuban experience
suggests that immune enhancement can be seen even 20 years after the prima
ry dengue virus infection. It also supports the contention that primary inf
ections with dengue virus type 2 (and dengue virus type 4) are largely subc
linical. These observations have implications for dengue vaccine developmen
t based on live-attenuated viruses.